Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Disney announces ad-supported Disney+ plan available in the U.S. » 11:03
12/08/22
12/08
11:03
12/08/22
11:03
DIS

Disney

$92.69 /

+0.55 (+0.60%)

Disney+ made its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

11/30/22 Atlantic Equities
Atlantic Equities sees 'no easy fix' for Iger at Disney
11/22/22 Tigress Financial
Disney price target lowered to $177 from $229 at Tigress Financial
11/21/22 JPMorgan
JPMorgan 'reluctant to recommend chasing' Disney shares on rally
11/21/22 Citi
Iger returning 'unalloyed positive' for Disney shares, says Citi
DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

Recommendations
Nvidia price target lowered to $250 from $310 at Tigress Financial » 09:33
12/08/22
12/08
09:33
12/08/22
09:33
NVDA

Nvidia

$161.18 /

+1.29 (+0.81%)

Tigress Financial analyst…

Tigress Financial analyst Ivan Feinseth lowered the firm's price target on Nvidia to $250 from $310 and keeps a Buy rating on the shares, citing a re-rating of valuation. His revised target represents a potential return of over 55% from current levels, noted Feinseth, who sees Nvidia's "industry-leading" position in Artificial Intelligence and multiple new products and partnerships enabling it to overcome near-term headwinds and position it for a new business upcycle.

ShowHide Related Items >><<
NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

11/17/22 Needham
Nvidia price target raised to $200 from $155 at Needham
11/17/22 Jefferies
Nvidia fundamentals bottoming, should grow through 2023, says Jefferies
11/17/22 Stifel
Nvidia price target raised to $175 from $165 at Stifel
11/17/22 Wedbush
Nvidia price target raised to $175 from $160 at Wedbush
NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

NVDA Nvidia
$161.18 /

+1.29 (+0.81%)

Yesterday
Hot Stocks
KULR Technology expands KULR VIBE offering with AI server platform » 08:34
12/07/22
12/07
08:34
12/07/22
08:34
KULR

KULR Technology

$1.68 /

+0.02 (+1.20%)

, NVDA

Nvidia

$159.89 /

-6.19 (-3.73%)

KULR Technology Group…

KULR Technology Group (KULR) announced that it will be expanding its vibration reduction solution KULR VIBE offering with the launch of a scalable, centralized artificial intelligence server platform. Powered by NVIDIA (NVDA) accelerators, the updated KULR VIBE system will deliver faster processing speeds and data capture for remote access. Of particular interest and request from KULR's enterprise customers, the cornerstone of this expansion will bring enhanced security to protect customer data, mission-critical projects and intellectual against potential cyber security risks.

ShowHide Related Items >><<
NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

KULR KULR Technology
$1.68 /

+0.02 (+1.20%)

KULR KULR Technology
$1.68 /

+0.02 (+1.20%)

NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

11/17/22 Needham
Nvidia price target raised to $200 from $155 at Needham
11/17/22 Jefferies
Nvidia fundamentals bottoming, should grow through 2023, says Jefferies
11/17/22 Stifel
Nvidia price target raised to $175 from $165 at Stifel
11/17/22 Wedbush
Nvidia price target raised to $175 from $160 at Wedbush
NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

NVDA Nvidia
$159.89 /

-6.19 (-3.73%)

Hot Stocks
Aehr Test Systems receives inital production order for FOX-XP multi-wafer test » 07:37
12/07/22
12/07
07:37
12/07/22
07:37
AEHR

Aehr Test Systems

$22.66 /

-2.9 (-11.35%)

Aehr Test Systems…

Aehr Test Systems announced it has received an initial production order from its new major silicon carbide semiconductor supplier customer for a FOX-XP multi-wafer test and burn-in system configured with Aehr's new fully integrated and automated WaferPak Aligner. The FOX-XP system is configured with Bipolar Voltage Channel Module and Very High Voltage Channel Module options which enable new advanced test and burn-in capabilities for silicon carbide power semiconductors using Aehr's proprietary WaferPak full wafer Contactors. This customer serves several significant markets including the electric vehicle industry as well as other industrial applications. This production system order is a follow-on to an order announced last quarter for a FOX-NP system that has already been installed at the customer's site. Shipments of the FOX-XP system with the new integrated and automated WaferPak Aligner are expected to begin in Aehr's fiscal fourth quarter that begins March 1, 2023.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$22.66 /

-2.9 (-11.35%)

AEHR Aehr Test Systems
$22.66 /

-2.9 (-11.35%)

10/17/22 William Blair
Aehr Test Systems initiated with an Outperform at William Blair
AEHR Aehr Test Systems
$22.66 /

-2.9 (-11.35%)

AEHR Aehr Test Systems
$22.66 /

-2.9 (-11.35%)

AEHR Aehr Test Systems
$22.66 /

-2.9 (-11.35%)

Tuesday
Conference/Events
Cantor biotech/biopharma analysts hold an analyst/industry conference call » 23:50
12/06/22
12/06
23:50
12/06/22
23:50
NVS

Novartis

$90.76 /

-0.23 (-0.25%)

, GILD

Gilead

$87.97 /

-0.05 (-0.06%)

, BMY

Bristol-Myers

$79.91 /

-0.79 (-0.98%)

, JNJ

Johnson & Johnson

$176.04 /

-2.75 (-1.54%)

, GRCL

Gracell

$2.55 /

-0.43 (-14.43%)

, PSTX

Poseida Therapeutics

$4.82 /

-0.27 (-5.30%)

, PGEN

Precigen

$1.58 /

-0.17 (-9.71%)

, MBIO

Mustang Bio

/

+

, ACLX

Arcellx

$19.01 /

-0.39 (-2.01%)

, ALLO

Allogene Therapeutics

$8.78 /

-0.575 (-6.15%)

, FATE

Fate Therapeutics

$19.18 /

-1.24 (-6.07%)

, HARP

Harpoon Therapeutics

/

+

Biopharma/Biotech…

Biopharma/Biotech Analysts Chen & Kim and Biotech Analyst Kluska, along with KOL speakers Dr. Dahiya, Asssoc Prof at University of Maryland and Dr. Ruella, Asst Prof at University of Pennsylvania discuss how next-generation CAR-T therapies could expand the market opportunity for these companies' treatments, including NVS, GILD, BMY, JNJ, GRCL, PSTX, PGEN, MBIO, ACLX, ALLO, FATE and HARP on an Analyst/Industry conference call to be held on December 14 at 1 pm. Webcast Link

ShowHide Related Items >><<
PSTX Poseida Therapeutics
$4.82 /

-0.27 (-5.30%)

PGEN Precigen
$1.58 /

-0.17 (-9.71%)

NVS Novartis
$90.76 /

-0.23 (-0.25%)

MBIO Mustang Bio
/

+

JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

HARP Harpoon Therapeutics
/

+

GRCL Gracell
$2.55 /

-0.43 (-14.43%)

GILD Gilead
$87.97 /

-0.05 (-0.06%)

FATE Fate Therapeutics
$19.18 /

-1.24 (-6.07%)

BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

ALLO Allogene Therapeutics
$8.78 /

-0.575 (-6.15%)

ACLX Arcellx
$19.01 /

-0.39 (-2.01%)

NVS Novartis
$90.76 /

-0.23 (-0.25%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
GILD Gilead
$87.97 /

-0.05 (-0.06%)

12/05/22 RBC Capital
Gilead discontinuation 'curious,' but shouldn't derail cancer momentum, says RBC
12/01/22 Oppenheimer
Gilead price target raised to $105 from $95 at Oppenheimer
11/22/22 Guggenheim
MacroGenics upgraded to Buy at Guggenheim ahead of near-term catalysts
11/09/22 Argus
Gilead price target raised to $100 from $70 at Argus
BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
11/17/22 Morgan Stanley
Ventyx Biosciences initiated with an Overweight at Morgan Stanley
11/14/22 BMO Capital
CytomX Therapeutics downgraded to Market Perform from Outperform at BMO Capital
11/02/22 Evercore ISI
Evercore starts Legend Biotech with an Outperform on Carvykti potential
JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
GRCL Gracell
$2.55 /

-0.43 (-14.43%)

09/22/22 Citi
Gracell initiated with a Buy at Citi
08/18/22 Wells Fargo
Gracell assumed with an Overweight at Wells Fargo
06/01/22 Cantor Fitzgerald
Gracell initiated with an Overweight at Cantor Fitzgerald
05/27/22 Piper Sandler
Gracell price target lowered to $10 from $25 at Piper Sandler
PSTX Poseida Therapeutics
$4.82 /

-0.27 (-5.30%)

11/11/22 BTIG
Poseida Therapeutics price target lowered to $14 from $20 at BTIG
08/09/22 Piper Sandler
Poseida Therapeutics price target raised to $11 from $9 at Piper Sandler
05/13/22 BTIG
Poseida Therapeutics price target lowered to $20 from $40 at BTIG
05/13/22 Piper Sandler
Poseida Therapeutics price target lowered to $9 from $19 at Piper Sandler
PGEN Precigen
$1.58 /

-0.17 (-9.71%)

11/18/22 Cantor Fitzgerald
Precigen initiated with an Overweight at Cantor Fitzgerald
11/18/22 Cantor Fitzgerald
Precigen initiated with an Overweight at Cantor Fitzgerald
08/09/22 H.C. Wainwright
Precigen price target lowered to $6 from $10 at H.C. Wainwright
07/05/22 Stifel
Precigen subsidiary sale relieves convertible debt overhang, says Stifel
MBIO Mustang Bio
/

+

11/16/22 BTIG
Mustang Bio price target lowered to $4 from $8 at BTIG
08/17/22 BTIG
Bluebird's approval has positive read for Mustang Bio, says BTIG
07/14/22 B. Riley
Mustang Bio price target lowered to $4 from $5 at B. Riley
05/23/22 B. Riley
Mustang Bio price target lowered to $5 from $6 at B. Riley
ACLX Arcellx
$19.01 /

-0.39 (-2.01%)

10/31/22 Guggenheim
Arcellx initiated with a Buy at Guggenheim
10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Canaccord
Arcellx initiated with a Buy at Canaccord
ALLO Allogene Therapeutics
$8.78 /

-0.575 (-6.15%)

11/21/22 H.C. Wainwright
Allogene Therapeutics price target lowered to $29 from $43 at H.C. Wainwright
09/22/22 B. Riley
Allogene Therapeutics price target lowered to $18 from $21 at B. Riley
09/20/22 B. Riley
B. Riley replaces Allogene with Syndax as top pick for 2022
08/10/22 Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
FATE Fate Therapeutics
$19.18 /

-1.24 (-6.07%)

11/16/22 Citi
Fate Therapeutics price target lowered to $80 from $87 at Citi
11/04/22 Cantor Fitzgerald
Fate Therapeutics assumed with an Overweight at Cantor Fitzgerald
10/10/22 Canaccord
Fate Therapeutics initiated with a Buy at Canaccord
08/18/22 Wells Fargo
Fate Therapeutics assumed with an Overweight at Wells Fargo
HARP Harpoon Therapeutics
/

+

11/15/22 Baird
Harpoon Therapeutics downgraded to Neutral from Outperform at Baird
08/29/22 Citi
Harpoon Therapeutics price target lowered to $6 from $7 at Citi
08/23/22 Truist
Harpoon Therapeutics price target lowered to $7 from $12 at Truist
08/15/22 H.C. Wainwright
Harpoon Therapeutics price target lowered to $7 from $18 at H.C. Wainwright
PSTX Poseida Therapeutics
$4.82 /

-0.27 (-5.30%)

PGEN Precigen
$1.58 /

-0.17 (-9.71%)

NVS Novartis
$90.76 /

-0.23 (-0.25%)

MBIO Mustang Bio
/

+

JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

HARP Harpoon Therapeutics
/

+

GRCL Gracell
$2.55 /

-0.43 (-14.43%)

GILD Gilead
$87.97 /

-0.05 (-0.06%)

FATE Fate Therapeutics
$19.18 /

-1.24 (-6.07%)

BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

ALLO Allogene Therapeutics
$8.78 /

-0.575 (-6.15%)

ACLX Arcellx
$19.01 /

-0.39 (-2.01%)

  • 04
    Aug
  • 17
    Jun
  • 04
    Feb
NVS Novartis
$90.76 /

-0.23 (-0.25%)

JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

NVS Novartis
$90.76 /

-0.23 (-0.25%)

JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

GRCL Gracell
$2.55 /

-0.43 (-14.43%)

GILD Gilead
$87.97 /

-0.05 (-0.06%)

FATE Fate Therapeutics
$19.18 /

-1.24 (-6.07%)

BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

ALLO Allogene Therapeutics
$8.78 /

-0.575 (-6.15%)

ACLX Arcellx
$19.01 /

-0.39 (-2.01%)

NVS Novartis
$90.76 /

-0.23 (-0.25%)

JNJ Johnson & Johnson
$176.04 /

-2.75 (-1.54%)

GILD Gilead
$87.97 /

-0.05 (-0.06%)

BMY Bristol-Myers
$79.91 /

-0.79 (-0.98%)

ACLX Arcellx
$19.01 /

-0.39 (-2.01%)

Hot Stocks
Lantheus announces pricing of offering of $500M convertible senior notes » 07:53
12/06/22
12/06
07:53
12/06/22
07:53
LNTH

Lantheus

$56.00 /

-5.36 (-8.74%)

Lantheus Holding…

Lantheus Holding announced the pricing of $500 million in aggregate principal amount of the Company's convertible senior notes due 2027. The Notes are being sold only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company also granted the initial purchasers of the Notes an option to purchase, within the 13-day period beginning on, and including, the initial closing date of the offering, up to an additional $75 million in aggregate principal amount of Notes. The sale of the Notes to the initial purchasers is expected to settle on or about December 8, 2022, subject to customary closing conditions, and is expected to result in approximately $485 million in net proceeds to the Company, after deducting the initial purchaser's discount and estimated offering expenses payable by the Company. The Notes will be senior unsecured obligations of the Company. The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Lantheus Medical Imaging, Inc., a direct wholly owned subsidiary of the Company. The Notes will bear interest at a rate of 2.625% per year, payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2023, and will mature on December 15, 2027, unless earlier redeemed, repurchased or converted. The initial conversion rate for the Notes is 12.5291 shares of the Company's common stock per $1,000 in principal amount of Notes. Prior to the close of business on the business day immediately preceding September 15, 2027, the Notes may be converted at the option of the holders only upon occurrence of specified events and during certain periods, and thereafter until the close of business on the business day immediately preceding the maturity date, the Notes may be converted at any time. The Company will satisfy any conversion by paying cash up to the aggregate principal amount of the Notes to be converted and by paying or delivering, as the case may be, cash, shares of the Company's common stock, or a combination of cash and shares of the Company's common stock, at its election, in respect of the remainder, if any, of its conversion obligation in excess of the aggregate principal amount of the Notes being converted. The Company may redeem for cash all or any portion of the Notes, at its option, on or after December 22, 2025 if the closing sale price per share of the Company's common stock exceeds 130% of the conversion price of the Notes for a specified period of time. The redemption price will be equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company's board of directors has authorized the repurchase of up to $150 million in aggregate amount of its common stock under certain circumstances. The Company expects to use approximately $75 million of the net proceeds from the offering of the Notes to repurchase shares of its common stock from purchasers of Notes in this offering in privately negotiated transactions effected with or through one of the initial purchasers or its affiliate. The Company expects the purchase price per share of the common stock repurchased in such transactions to equal the closing sale price per share of its common stock on December 5, 2022, which was $56.01 per share. These repurchases could increase, or prevent a decrease in, the market price of the Company's common stock or the Notes concurrently with the pricing of the Notes, and could result in a higher effective conversion price for the Notes. The Company intends to use the remainder of the net proceeds from the offering of the Notes for general corporate purposes, including other repurchases of its common stock from time to time in an amount up to $75 million, working capital, capital expenditures, refinancing or repaying debt, payments related to the previously announced license and collaboration agreements with POINT Biopharma Global Inc. and with an affiliate thereof if the transactions contemplated by such agreements are consummated, potential acquisitions and strategic transactions.

ShowHide Related Items >><<
LNTH Lantheus
$56.00 /

-5.36 (-8.74%)

LNTH Lantheus
$56.00 /

-5.36 (-8.74%)

11/15/22 Truist
Point Biopharma price target lowered to $14 from $22 at Truist
11/14/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
10/12/22 Mizuho
Lantheus initiated with a Buy at Mizuho
10/06/22 JonesTrading
Lantheus initiated with a Buy at JonesTrading
LNTH Lantheus
$56.00 /

-5.36 (-8.74%)

LNTH Lantheus
$56.00 /

-5.36 (-8.74%)

Monday
On The Fly
What You Missed On Wall Street On Monday » 16:52
12/05/22
12/05
16:52
12/05/22
16:52
CRM

Salesforce

$133.87 /

-10.695 (-7.40%)

, IOVA

Iovance Biotherapeutics

$8.04 /

+1.195 (+17.46%)

, BP

BP

$35.01 /

-0.355 (-1.00%)

, COP

ConocoPhillips

$119.37 /

-2.385 (-1.96%)

, SHEL

Shell

$57.41 /

-0.29 (-0.50%)

, TTE

TotalEnergies

$59.71 /

-0.97 (-1.60%)

, XOM

Exxon Mobil

$106.80 /

-3.035 (-2.76%)

, CVX

Chevron

$176.63 /

-4.32 (-2.39%)

, USO

United States Oil Fund

$67.71 /

-2.13 (-3.05%)

, VFC

VF Corp.

$29.52 /

-3.7 (-11.14%)

, NBTB

NBT Bancorp

$43.38 /

-2.94 (-6.35%)

, SAL

Salisbury Bancorp

$31.23 /

+0.14 (+0.45%)

, TSLA

Tesla

$182.42 /

-12.43 (-6.38%)

, AAPL

Apple

$146.61 /

-1.21 (-0.82%)

, SBUX

Starbucks

$103.59 /

-1.44 (-1.37%)

, DPZ

Domino's Pizza

$380.98 /

-1.24 (-0.32%)

, UAL

United Airlines

$45.03 /

+1.14 (+2.60%)

, MGM

MGM Resorts

$37.81 /

+0.74 (+2.00%)

, SI

Silvergate Capital

$24.24 /

-2.225 (-8.41%)

, RXT

Rackspace Technology

$4.10 /

-0.75 (-15.48%)

, CVS

CVS Health

$102.01 /

-0.55 (-0.54%)

, PINS

Pinterest

$23.96 /

-0.895 (-3.60%)

, NKE

Nike

$109.64 /

-2.55 (-2.27%)

, CS

Credit Suisse

$3.35 /

-0.035 (-1.04%)

, CWK

Cushman & Wakefield

$12.26 /

+0.295 (+2.47%)

, HZNP

Horizon Therapeutics

$98.55 /

-6.275 (-5.99%)

, JNJ

Johnson & Johnson

$178.79 /

-0.05 (-0.03%)

, FTCH

Farfetch

$5.45 /

-0.54 (-9.02%)

, SAIC

SAIC

$113.98 /

+5.145 (+4.73%)

, VERU

Veru

$5.80 /

+0.295 (+5.36%)

, SLG

SL Green Realty

$38.07 /

-2.58 (-6.35%)

, ENLV

Enlivex Therapeutics

$4.41 /

-0.07 (-1.56%)

, NTRB

Nutriband

$3.82 /

+0.045 (+1.19%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Credit Suisse
Salesforce price target lowered to $225 from $250 at Credit Suisse
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
BP BP
$35.01 /

-0.355 (-1.00%)

12/02/22 JPMorgan
BP price target raised to 560 GBp from 530 GBp at JPMorgan
11/22/22 Citi
BP upgraded to Buy from Neutral at Citi
11/14/22 Wells Fargo
Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Piper Sandler
BP price target raised to $40 from $37 at Piper Sandler
COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

11/22/22 Citi
ConocoPhillips price target raised to $160 from $132 at Citi
11/21/22 Argus
ConocoPhillips price target raised to $150 from $125 at Argus
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell on valuation at Societe Generale
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell from Hold at Societe Generale
SHEL Shell
$57.41 /

-0.29 (-0.50%)

12/02/22 JPMorgan
Shell price target raised to 2,950 GBp from 2,900 GBp at JPMorgan
11/11/22 Piper Sandler
Shell price target raised to $71 from $65 at Piper Sandler
11/08/22 Morgan Stanley
Shell price target raised to 2,922 GBp from 2,860 GBp at Morgan Stanley
11/06/22 Goldman Sachs
Shell downgraded to Neutral from Buy at Goldman Sachs
TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

12/02/22 JPMorgan
TotalEnergies price target raised to EUR 68 from EUR 66 at JPMorgan
12/02/22 JPMorgan
TotalEnergies added to Analyst Focus List at JPMorgan
11/11/22 Piper Sandler
TotalEnergies price target raised to $66 from $58 at Piper Sandler
11/08/22 Morgan Stanley
TotalEnergies price target raised to EUR 65 from EUR 58 at Morgan Stanley
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
10/31/22 Truist
Exxon Mobil price target raised to $114 from $111 at Truist
CVX Chevron
$176.63 /

-4.32 (-2.39%)

11/22/22 Citi
Chevron price target raised to $180 from $155 at Citi
11/11/22 Piper Sandler
Chevron price target raised to $206 from $186 at Piper Sandler
10/31/22 Cowen
Chevron price target raised to $185 from $160 at Cowen
10/24/22 HSBC
Chevron downgraded to Hold from Buy at HSBC
USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

12/06/22 Baird
VF Corp. removed from bullish Fresh Pick at Baird
12/05/22 Deutsche Bank
VF Corp. risk/reward favorable with bar reset, says Deutsche Bank
12/05/22 Credit Suisse
Credit Suisse downgrades VF Corp. after 'abrupt' CEO transition
12/05/22 Credit Suisse
VF Corp. downgraded to Neutral from Outperform at Credit Suisse
NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral at Janney after NBT Bancorp deal
01/09/22 Keefe Bruyette
NBT Bancorp assumed with a Market Perform at Keefe Bruyette
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
TSLA Tesla
$182.42 /

-12.43 (-6.38%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

12/05/22 Deutsche Bank
Starbucks downgraded to Hold from Buy at Deutsche Bank
11/04/22 Evercore ISI
Starbucks price target raised to $97 from $95 at Evercore ISI
11/04/22 Citi
Starbucks price target raised to $93 from $90 at Citi
11/04/22 Wedbush
Starbucks price target raised to $96 from $92 at Wedbush
DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

12/05/22 BTIG
Domino's Pizza upgraded to Buy from Neutral at BTIG
11/30/22 Citi
Domino's Pizza price target raised to $441 from $407 at Citi
11/18/22 Northcoast
Domino's Pizza upgraded to Buy from Neutral at Northcoast
10/14/22 BMO Capital
Domino's Pizza price target lowered to $400 from $430 at BMO Capital
UAL United Airlines
$45.03 /

+1.14 (+2.60%)

12/06/22 Argus
United Airlines upgraded to Buy from Hold at Argus
12/05/22 Morgan Stanley
United Airlines upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/22 Cowen
Mesa Air price target lowered to $1.50 from $4.00 at Cowen
10/21/22 Citi
United Airlines price target raised to $65 from $56 at Citi
MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

12/05/22 Truist
MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip
12/05/22 Truist
MGM Resorts upgraded to Buy from Hold at Truist
11/28/22 Jefferies
Macau concession renewals removes overhang for incumbents, says Jefferies
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
11/29/22 Keefe Bruyette
Silvergate exposure to BlockFi 'very modest,' says Keefe Bruyette
11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

11/21/22 Citi
Rackspace Technology price target lowered to $5 from $7 at Citi
11/10/22 Deutsche Bank
Rackspace Technology price target lowered to $5 from $6 at Deutsche Bank
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line at Evercore ISI on 2023 risks
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line from Outperform at Evercore ISI
CVS CVS Health
$102.01 /

-0.55 (-0.54%)

11/23/22 Morgan Stanley
CVS Health assumed with an Overweight at Morgan Stanley
11/21/22 Credit Suisse
CVS Health price target raised to $125 from $117 at Credit Suisse
11/06/22 Raymond James
CVS Health price target lowered to $115 from $120 at Raymond James
11/02/22 B. Riley
B. Riley downgrades Semler Scientific on risk from Signify buyout
PINS Pinterest
$23.96 /

-0.895 (-3.60%)

10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
10/28/22 Piper Sandler
Pinterest price target raised to $25 from $23 at Piper Sandler
NKE Nike
$109.64 /

-2.55 (-2.27%)

11/22/22 Cowen
Nike price target raised to $118 from $114 at Cowen
11/07/22 Stifel
Deckers Brands price target raised to $416 from $390 at Stifel
10/13/22 Raymond James
Nike initiated with an Outperform at Raymond James
10/12/22 Raymond James
Nike initiated with an Outperform at Raymond James
CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

12/01/22 JPMorgan
Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
11/07/22 AlphaValue/Baader
Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
10/28/22 JPMorgan
Credit Suisse price target lowered to CHF 5.50 from CHF 6 at JPMorgan
10/06/22 JPMorgan
Credit Suisse upgraded to Neutral from Underweight at JPMorgan
CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

07/22/22 Raymond James
Cushman & Wakefield removed from Analyst Current Favorites list at Raymond James
04/21/22 Citi
Cushman & Wakefield price target lowered to $21 from $23 at Citi
04/05/22 Goldman Sachs
Cushman & Wakefield initiated with a Buy at Goldman Sachs
03/10/22 Wolfe Research
Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research
HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

12/05/22 Cowen
Farfetch price target lowered to $8 from $11 at Cowen
12/02/22 Wells Fargo
Farfetch price target lowered to $18 from $25 at Wells Fargo
12/02/22 JPMorgan
Farfetch selloff on financial outlook overdone, says JPMorgan
12/02/22 BTIG
Farfetch price target lowered to $10 from $13 at BTIG
SAIC SAIC
$113.98 /

+5.145 (+4.73%)

12/06/22 Truist
SAIC price target raised to $120 from $105 at Truist
12/06/22 Wells Fargo
SAIC price target raised to $121 from $99 at Wells Fargo
12/05/22 Stifel
SAIC price target raised to $110 from $99 at Stifel
11/17/22 Jefferies
SAIC downgraded to Hold at Jefferies on lower growth than peers
VERU Veru
$5.80 /

+0.295 (+5.36%)

11/10/22 H.C. Wainwright
Veru price target lowered to $21 from $24 at H.C. Wainwright
09/20/22 Oppenheimer
Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
09/08/22 Oppenheimer
Oppenheimer remains bullish on Veru, optimism for EUA unchanged
08/11/22 Cantor Fitzgerald
Veru price target raised to $30 from $24 at Cantor Fitzgerald
SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

12/06/22 Scotiabank
Scotiabank downgrades SL Green with balance sheet looking 'stressed'
12/06/22 BMO Capital
SL Green Realty downgraded to Market Perform from Outperform at BMO Capital
12/06/22 Scotiabank
SL Green Realty downgraded to Underperform from Sector Perform at Scotiabank
11/23/22 Morgan Stanley
SL Green Realty price target lowered to $38 from $44 at Morgan Stanley
ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

05/02/22 H.C. Wainwright
Enlivex Therapeutics price target lowered to $15 from $33 at H.C. Wainwright
NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

  • 07
    Dec
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

On The Fly
What You Missed On Wall Street This Morning » 12:37
12/05/22
12/05
12:37
12/05/22
12:37
VFC

VF Corp.

$30.16 /

-3.06 (-9.21%)

, SAL

Salisbury Bancorp

$31.51 /

+0.42 (+1.35%)

, NBTB

NBT Bancorp

$43.67 /

-2.65 (-5.72%)

, BP

BP

$35.25 /

-0.115 (-0.33%)

, COP

ConocoPhillips

$121.33 /

-0.42 (-0.34%)

, SHEL

Shell

$57.71 /

+0.015 (+0.03%)

, TTE

TotalEnergies

$60.36 /

-0.32 (-0.53%)

, XOM

Exxon Mobil

$107.84 /

-2 (-1.82%)

, CVX

Chevron

$178.06 /

-2.89 (-1.60%)

, USO

United States Oil Fund

$68.72 /

-1.12 (-1.60%)

, TSLA

Tesla

$184.67 /

-10.18 (-5.22%)

, AAPL

Apple

$147.10 /

-0.72 (-0.49%)

, RXT

Rackspace Technology

$4.34 /

-0.505 (-10.42%)

, LYV

Live Nation

$73.73 /

-0.23 (-0.31%)

, T

AT&T

$18.77 /

-0.24 (-1.26%)

, CVS

CVS Health

$101.88 /

-0.68 (-0.66%)

, ABBV

AbbVie

$164.13 /

+0.48 (+0.29%)

, AVXL

Anavex

$10.78 /

-1.25 (-10.39%)

, PATH

UiPath

$13.56 /

-0.97 (-6.68%)

, SPB

Spectrum Brands

$62.85 /

-3.86 (-5.79%)

, ASAZY

Assa Abloy

$11.66 /

-0.025 (-0.21%)

, MRVL

Marvell

$43.64 /

-1.09 (-2.44%)

, CHPT

ChargePoint

$11.67 /

+0.03 (+0.26%)

, SAIC

SAIC

$114.47 /

+5.64 (+5.18%)

, VERU

Veru

$5.82 /

+0.315 (+5.72%)

, SLG

SL Green Realty

$38.54 /

-2.11 (-5.19%)

, ENLV

Enlivex Therapeutics

$4.35 /

-0.13 (-2.90%)

, NTRB

Nutriband

$3.87 /

+0.09 (+2.38%)

, SBUX

Starbucks

$103.75 /

-1.28 (-1.22%)

, DPZ

Domino's Pizza

$384.00 /

+1.78 (+0.47%)

, UAL

United Airlines

$45.06 /

+1.17 (+2.67%)

, MGM

MGM Resorts

$37.99 /

+0.92 (+2.48%)

, SI

Silvergate Capital

$24.71 /

-1.75 (-6.61%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

VFC VF Corp.
$30.16 /

-3.06 (-9.21%)

VERU Veru
$5.82 /

+0.315 (+5.72%)

USO United States Oil Fund
$68.72 /

-1.12 (-1.60%)

UAL United Airlines
$45.06 /

+1.17 (+2.67%)

TTE TotalEnergies
$60.36 /

-0.32 (-0.53%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

T AT&T
$18.77 /

-0.24 (-1.26%)

SPB Spectrum Brands
$62.85 /

-3.86 (-5.79%)

SLG SL Green Realty
$38.54 /

-2.11 (-5.19%)

SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

SHEL Shell
$57.71 /

+0.015 (+0.03%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

SAL Salisbury Bancorp
$31.51 /

+0.42 (+1.35%)

SAIC SAIC
$114.47 /

+5.64 (+5.18%)

RXT Rackspace Technology
$4.34 /

-0.505 (-10.42%)

PATH UiPath
$13.56 /

-0.97 (-6.68%)

NTRB Nutriband
$3.87 /

+0.09 (+2.38%)

MRVL Marvell
$43.64 /

-1.09 (-2.44%)

MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

LYV Live Nation
$73.73 /

-0.23 (-0.31%)

ENLV Enlivex Therapeutics
$4.35 /

-0.13 (-2.90%)

DPZ Domino's Pizza
$384.00 /

+1.78 (+0.47%)

CVX Chevron
$178.06 /

-2.89 (-1.60%)

CVS CVS Health
$101.88 /

-0.68 (-0.66%)

COP ConocoPhillips
$121.33 /

-0.42 (-0.34%)

CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

BP BP
$35.25 /

-0.115 (-0.33%)

AVXL Anavex
$10.78 /

-1.25 (-10.39%)

ASAZY Assa Abloy
$11.66 /

-0.025 (-0.21%)

ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

AAPL Apple
$147.10 /

-0.72 (-0.49%)

VFC VF Corp.
$30.16 /

-3.06 (-9.21%)

12/05/22 Credit Suisse
Credit Suisse downgrades VF Corp. after 'abrupt' CEO transition
12/05/22 Credit Suisse
VF Corp. downgraded to Neutral from Outperform at Credit Suisse
12/01/22 Baird
VF Corp. price target raised to $42 from $40 at Baird
11/29/22 JPMorgan
VF Corp. price target lowered to $27 from $29 at JPMorgan
SAL Salisbury Bancorp
$31.51 /

+0.42 (+1.35%)

NBTB NBT Bancorp
$43.67 /

-2.65 (-5.72%)

01/09/22 Keefe Bruyette
NBT Bancorp assumed with a Market Perform at Keefe Bruyette
BP BP
$35.25 /

-0.115 (-0.33%)

12/02/22 JPMorgan
BP price target raised to 560 GBp from 530 GBp at JPMorgan
11/22/22 Citi
BP upgraded to Buy from Neutral at Citi
11/14/22 Wells Fargo
Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Piper Sandler
BP price target raised to $40 from $37 at Piper Sandler
COP ConocoPhillips
$121.33 /

-0.42 (-0.34%)

11/22/22 Citi
ConocoPhillips price target raised to $160 from $132 at Citi
11/21/22 Argus
ConocoPhillips price target raised to $150 from $125 at Argus
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell on valuation at Societe Generale
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell from Hold at Societe Generale
SHEL Shell
$57.71 /

+0.015 (+0.03%)

12/02/22 JPMorgan
Shell price target raised to 2,950 GBp from 2,900 GBp at JPMorgan
11/11/22 Piper Sandler
Shell price target raised to $71 from $65 at Piper Sandler
11/08/22 Morgan Stanley
Shell price target raised to 2,922 GBp from 2,860 GBp at Morgan Stanley
11/06/22 Goldman Sachs
Shell downgraded to Neutral from Buy at Goldman Sachs
TTE TotalEnergies
$60.36 /

-0.32 (-0.53%)

12/02/22 JPMorgan
TotalEnergies price target raised to EUR 68 from EUR 66 at JPMorgan
12/02/22 JPMorgan
TotalEnergies added to Analyst Focus List at JPMorgan
11/11/22 Piper Sandler
TotalEnergies price target raised to $66 from $58 at Piper Sandler
11/08/22 Morgan Stanley
TotalEnergies price target raised to EUR 65 from EUR 58 at Morgan Stanley
XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
10/31/22 Truist
Exxon Mobil price target raised to $114 from $111 at Truist
CVX Chevron
$178.06 /

-2.89 (-1.60%)

11/22/22 Citi
Chevron price target raised to $180 from $155 at Citi
11/11/22 Piper Sandler
Chevron price target raised to $206 from $186 at Piper Sandler
10/31/22 Cowen
Chevron price target raised to $185 from $160 at Cowen
10/24/22 HSBC
Chevron downgraded to Hold from Buy at HSBC
USO United States Oil Fund
$68.72 /

-1.12 (-1.60%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
11/23/22 Citi
Tesla upgraded to Neutral from Sell at Citi
AAPL Apple
$147.10 /

-0.72 (-0.49%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
RXT Rackspace Technology
$4.34 /

-0.505 (-10.42%)

11/21/22 Citi
Rackspace Technology price target lowered to $5 from $7 at Citi
11/10/22 Deutsche Bank
Rackspace Technology price target lowered to $5 from $6 at Deutsche Bank
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line at Evercore ISI on 2023 risks
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line from Outperform at Evercore ISI
LYV Live Nation
$73.73 /

-0.23 (-0.31%)

11/30/22 Morgan Stanley
Live Nation price target lowered to $80 from $95 at Morgan Stanley
11/28/22 Citi
Live Nation upgraded to Buy from Neutral at Citi
11/22/22 Redburn
Redburn starts Live Nation with a Neutral
11/22/22 Redburn
Live Nation initiated with a Neutral at Redburn
T AT&T
$18.77 /

-0.24 (-1.26%)

11/14/22 Wells Fargo
Dycom price target lowered to $120 from $130 at Wells Fargo
10/24/22 Raymond James
AT&T upgraded to Strong Buy from Outperform at Raymond James
10/24/22 Barclays
AT&T price target raised to $19 from $18 at Barclays
10/24/22 Raymond James
AT&T upgraded to Strong Buy from Outperform at Raymond James
CVS CVS Health
$101.88 /

-0.68 (-0.66%)

11/23/22 Morgan Stanley
CVS Health assumed with an Overweight at Morgan Stanley
11/21/22 Credit Suisse
CVS Health price target raised to $125 from $117 at Credit Suisse
11/06/22 Raymond James
CVS Health price target lowered to $115 from $120 at Raymond James
11/02/22 B. Riley
B. Riley downgrades Semler Scientific on risk from Signify buyout
ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

11/17/22 Credit Suisse
AbbVie initiated with an Outperform at Credit Suisse
11/08/22 Societe Generale
AbbVie downgraded at Societe Generale on blood cancer and aesthetics headwinds
11/08/22 Societe Generale
AbbVie downgraded to Hold from Buy at Societe Generale
10/28/22 Piper Sandler
Piper keeps Overweight rating on AbbVie despite 'rough' Q3 report
AVXL Anavex
$10.78 /

-1.25 (-10.39%)

12/02/22 JonesTrading
Anavex price target raised to $80 from $40 at JonesTrading
06/23/22 Berenberg
Anavex initiated with a Buy at Berenberg
02/02/22 Cantor Fitzgerald
Anavex price target lowered to $16 from $27 at Cantor Fitzgerald
PATH UiPath
$13.56 /

-0.97 (-6.68%)

12/02/22 Truist
UiPath price target lowered to $20 from $25 at Truist
12/02/22 Mizuho
UiPath price target raised to $15 from $14 at Mizuho
11/03/22 Oppenheimer
UiPath downgraded to Perform from Outperform at Oppenheimer
10/18/22 Barclays
UiPath downgraded to Equal Weight on 'digestive phase' at Barclays
SPB Spectrum Brands
$62.85 /

-3.86 (-5.79%)

11/23/22 UBS
Spectrum Brands price target lowered to $84 from $91 at UBS
11/21/22 Deutsche Bank
Spectrum Brands price target lowered to $63 from $68 at Deutsche Bank
09/16/22 Deutsche Bank
Spectrum Brands price target lowered to $68 from $90 at Deutsche Bank
08/15/22 Deutsche Bank
Spectrum Brands price target lowered to $90 from $95 at Deutsche Bank
ASAZY Assa Abloy
$11.66 /

-0.025 (-0.21%)

11/30/22 Exane BNP Paribas
Assa Abloy upgraded to Neutral from Underperform at Exane BNP Paribas
11/22/22 Morgan Stanley
Assa Abloy assumed with an Equal Weight at Morgan Stanley
11/08/22 Berenberg
Assa Abloy downgraded to Hold from Buy at Berenberg
11/07/22 Societe Generale
Assa Abloy downgraded to Hold from Buy at Societe Generale
MRVL Marvell
$43.64 /

-1.09 (-2.44%)

12/02/22 Craig-Hallum
Marvell price target lowered to $63 from $90 at Craig-Hallum
12/02/22 BMO Capital
Marvell price target lowered to $65 from $75 at BMO Capital
12/02/22 Jefferies
Jefferies would 'buy the confession' after Marvell guidance miss
12/02/22 Cowen
Marvell price target lowered to $55 from $70 at Cowen
CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

12/05/22 DA Davidson
ChargePoint price target lowered to $18 from $20 at DA Davidson
12/02/22 R.F. Lafferty
ChargePoint price target lowered to $28 from $34 at R.F. Lafferty
12/02/22 Oppenheimer
ChargePoint price target lowered to $26 from $40 at Oppenheimer
11/29/22 Citi
ChargePoint price target lowered to $14 from $15.50 at Citi
SAIC SAIC
$114.47 /

+5.64 (+5.18%)

11/17/22 Jefferies
SAIC downgraded to Hold at Jefferies on lower growth than peers
11/17/22 Jefferies
SAIC downgraded to Hold from Buy at Jefferies
06/07/22 Cowen
SAIC price target raised to $120 from $111 at Cowen
06/07/22 Barclays
SAIC price target raised to $95 from $90 at Barclays
VERU Veru
$5.82 /

+0.315 (+5.72%)

11/10/22 H.C. Wainwright
Veru price target lowered to $21 from $24 at H.C. Wainwright
09/20/22 Oppenheimer
Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
09/08/22 Oppenheimer
Oppenheimer remains bullish on Veru, optimism for EUA unchanged
08/11/22 Cantor Fitzgerald
Veru price target raised to $30 from $24 at Cantor Fitzgerald
SLG SL Green Realty
$38.54 /

-2.11 (-5.19%)

11/23/22 Morgan Stanley
SL Green Realty price target lowered to $38 from $44 at Morgan Stanley
10/25/22 Truist
SL Green Realty price target lowered to $51 from $59 at Truist
10/19/22 BTIG
SL Green Realty price target lowered to $84 from $105 at BTIG
10/19/22 Mizuho
SL Green Realty price target lowered to $48 from $55 at Mizuho
ENLV Enlivex Therapeutics
$4.35 /

-0.13 (-2.90%)

05/02/22 H.C. Wainwright
Enlivex Therapeutics price target lowered to $15 from $33 at H.C. Wainwright
NTRB Nutriband
$3.87 /

+0.09 (+2.38%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

12/05/22 Deutsche Bank
Starbucks downgraded to Hold from Buy at Deutsche Bank
11/04/22 Evercore ISI
Starbucks price target raised to $97 from $95 at Evercore ISI
11/04/22 Citi
Starbucks price target raised to $93 from $90 at Citi
11/04/22 Wedbush
Starbucks price target raised to $96 from $92 at Wedbush
DPZ Domino's Pizza
$384.00 /

+1.78 (+0.47%)

12/05/22 BTIG
Domino's Pizza upgraded to Buy from Neutral at BTIG
11/30/22 Citi
Domino's Pizza price target raised to $441 from $407 at Citi
11/18/22 Northcoast
Domino's Pizza upgraded to Buy from Neutral at Northcoast
10/14/22 BMO Capital
Domino's Pizza price target lowered to $400 from $430 at BMO Capital
UAL United Airlines
$45.06 /

+1.17 (+2.67%)

12/05/22 Morgan Stanley
United Airlines upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/22 Cowen
Mesa Air price target lowered to $1.50 from $4.00 at Cowen
10/21/22 Citi
United Airlines price target raised to $65 from $56 at Citi
10/20/22 BofA
United Airlines price target raised to $40 from $35 at BofA
MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

12/05/22 Truist
MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip
12/05/22 Truist
MGM Resorts upgraded to Buy from Hold at Truist
11/28/22 Jefferies
Macau concession renewals removes overhang for incumbents, says Jefferies
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
11/29/22 Keefe Bruyette
Silvergate exposure to BlockFi 'very modest,' says Keefe Bruyette
11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

VFC VF Corp.
$30.16 /

-3.06 (-9.21%)

VERU Veru
$5.82 /

+0.315 (+5.72%)

UAL United Airlines
$45.06 /

+1.17 (+2.67%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

T AT&T
$18.77 /

-0.24 (-1.26%)

SPB Spectrum Brands
$62.85 /

-3.86 (-5.79%)

SLG SL Green Realty
$38.54 /

-2.11 (-5.19%)

SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

SHEL Shell
$57.71 /

+0.015 (+0.03%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

SAIC SAIC
$114.47 /

+5.64 (+5.18%)

RXT Rackspace Technology
$4.34 /

-0.505 (-10.42%)

PATH UiPath
$13.56 /

-0.97 (-6.68%)

NTRB Nutriband
$3.87 /

+0.09 (+2.38%)

NBTB NBT Bancorp
$43.67 /

-2.65 (-5.72%)

MRVL Marvell
$43.64 /

-1.09 (-2.44%)

MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

LYV Live Nation
$73.73 /

-0.23 (-0.31%)

ENLV Enlivex Therapeutics
$4.35 /

-0.13 (-2.90%)

DPZ Domino's Pizza
$384.00 /

+1.78 (+0.47%)

CVX Chevron
$178.06 /

-2.89 (-1.60%)

CVS CVS Health
$101.88 /

-0.68 (-0.66%)

COP ConocoPhillips
$121.33 /

-0.42 (-0.34%)

CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

BP BP
$35.25 /

-0.115 (-0.33%)

AVXL Anavex
$10.78 /

-1.25 (-10.39%)

ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

AAPL Apple
$147.10 /

-0.72 (-0.49%)

  • 07
    Dec
XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

VERU Veru
$5.82 /

+0.315 (+5.72%)

USO United States Oil Fund
$68.72 /

-1.12 (-1.60%)

UAL United Airlines
$45.06 /

+1.17 (+2.67%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

T AT&T
$18.77 /

-0.24 (-1.26%)

SPB Spectrum Brands
$62.85 /

-3.86 (-5.79%)

SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

SHEL Shell
$57.71 /

+0.015 (+0.03%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

RXT Rackspace Technology
$4.34 /

-0.505 (-10.42%)

MRVL Marvell
$43.64 /

-1.09 (-2.44%)

MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

LYV Live Nation
$73.73 /

-0.23 (-0.31%)

CVX Chevron
$178.06 /

-2.89 (-1.60%)

CVS CVS Health
$101.88 /

-0.68 (-0.66%)

CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

BP BP
$35.25 /

-0.115 (-0.33%)

ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

AAPL Apple
$147.10 /

-0.72 (-0.49%)

XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

VFC VF Corp.
$30.16 /

-3.06 (-9.21%)

VERU Veru
$5.82 /

+0.315 (+5.72%)

UAL United Airlines
$45.06 /

+1.17 (+2.67%)

TTE TotalEnergies
$60.36 /

-0.32 (-0.53%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

T AT&T
$18.77 /

-0.24 (-1.26%)

SPB Spectrum Brands
$62.85 /

-3.86 (-5.79%)

SLG SL Green Realty
$38.54 /

-2.11 (-5.19%)

SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

SHEL Shell
$57.71 /

+0.015 (+0.03%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

SAIC SAIC
$114.47 /

+5.64 (+5.18%)

RXT Rackspace Technology
$4.34 /

-0.505 (-10.42%)

PATH UiPath
$13.56 /

-0.97 (-6.68%)

MRVL Marvell
$43.64 /

-1.09 (-2.44%)

MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

LYV Live Nation
$73.73 /

-0.23 (-0.31%)

ENLV Enlivex Therapeutics
$4.35 /

-0.13 (-2.90%)

DPZ Domino's Pizza
$384.00 /

+1.78 (+0.47%)

CVX Chevron
$178.06 /

-2.89 (-1.60%)

CVS CVS Health
$101.88 /

-0.68 (-0.66%)

COP ConocoPhillips
$121.33 /

-0.42 (-0.34%)

CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

BP BP
$35.25 /

-0.115 (-0.33%)

AVXL Anavex
$10.78 /

-1.25 (-10.39%)

ASAZY Assa Abloy
$11.66 /

-0.025 (-0.21%)

ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

AAPL Apple
$147.10 /

-0.72 (-0.49%)

XOM Exxon Mobil
$107.84 /

-2 (-1.82%)

VFC VF Corp.
$30.16 /

-3.06 (-9.21%)

VERU Veru
$5.82 /

+0.315 (+5.72%)

USO United States Oil Fund
$68.72 /

-1.12 (-1.60%)

UAL United Airlines
$45.06 /

+1.17 (+2.67%)

TSLA Tesla
$184.67 /

-10.18 (-5.22%)

T AT&T
$18.77 /

-0.24 (-1.26%)

SLG SL Green Realty
$38.54 /

-2.11 (-5.19%)

SI Silvergate Capital
$24.71 /

-1.75 (-6.61%)

SHEL Shell
$57.71 /

+0.015 (+0.03%)

SBUX Starbucks
$103.75 /

-1.28 (-1.22%)

PATH UiPath
$13.56 /

-0.97 (-6.68%)

MRVL Marvell
$43.64 /

-1.09 (-2.44%)

MGM MGM Resorts
$37.99 /

+0.92 (+2.48%)

LYV Live Nation
$73.73 /

-0.23 (-0.31%)

DPZ Domino's Pizza
$384.00 /

+1.78 (+0.47%)

CVX Chevron
$178.06 /

-2.89 (-1.60%)

CVS CVS Health
$101.88 /

-0.68 (-0.66%)

COP ConocoPhillips
$121.33 /

-0.42 (-0.34%)

CHPT ChargePoint
$11.67 /

+0.03 (+0.26%)

BP BP
$35.25 /

-0.115 (-0.33%)

AVXL Anavex
$10.78 /

-1.25 (-10.39%)

ABBV AbbVie
$164.13 /

+0.48 (+0.29%)

AAPL Apple
$147.10 /

-0.72 (-0.49%)

Hot Stocks
Lantheus announces proposed offering of $500M convertible senior notes » 07:12
12/05/22
12/05
07:12
12/05/22
07:12
LNTH

Lantheus

$61.32 /

+0.08 (+0.13%)

Lantheus Holdings…

Lantheus Holdings announced that it intends to offer, subject to market conditions and other factors, $500 million in aggregate principal amount of the Company's convertible senior notes due 2027. The Notes are to be offered and sold only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended. The Company also expects to grant the initial purchasers of the Notes an option to purchase, within the 13-day period beginning on, and including, the initial closing date of the offering, up to an additional $75 million in aggregate principal amount of Notes. The Notes will be senior unsecured obligations of the Company. The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Lantheus Medical Imaging, Inc., a direct wholly owned subsidiary of the Company. The Notes will mature on December 15, 2027, unless earlier redeemed, repurchased or converted. The Notes are expected to pay interest semi-annually in arrears. Prior to the close of business on the business day immediately preceding September 15, 2027, the Notes may be converted at the option of the holders only upon occurrence of specified events and during certain periods, and thereafter until the close of business on the business day immediately preceding the maturity date, the Notes may be converted at any time. The Company will satisfy any conversion by paying cash up to the aggregate principal amount of the Notes to be converted and by paying or delivering, as the case may be, cash, shares of the Company's common stock, or a combination of cash and shares of the Company's common stock, at its election, in respect of the remainder, if any, of its conversion obligation in excess of the aggregate principal amount of the Notes being converted. The Company may redeem for cash all or any portion of the Notes, at its option, on or after December 22, 2025 if the closing sale price per share of the Company's common stock exceeds 130% of the conversion price of the Notes for a specified period of time. The redemption price will be equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. The interest rate, the initial conversion rate and the other terms of the Notes will be determined upon pricing of the offering by negotiations between the Company and the initial purchasers of the Notes. The Company's board of directors has authorized the repurchase of up to $150 million in aggregate amount of its common stock under certain circumstances. The Company expects to use up to $75 million of the net proceeds from the offering of the Notes to repurchase shares of its common stock from purchasers of Notes in this offering in privately negotiated transactions effected with or through one of the initial purchasers or its affiliate. These repurchases could increase, or prevent a decrease in, the market price of the Company's common stock or the Notes concurrently with the pricing of the Notes, and could result in a higher effective conversion price for the Notes. The Company intends to use the remainder of the net proceeds from the offering of the Notes for general corporate purposes, including other repurchases of its common stock from time to time in an amount up to $75 million, working capital, capital expenditures, refinancing or repaying debt, payments related to the previously announced license and collaboration agreements with POINT Biopharma Global Inc. and with an affiliate thereof if the transactions contemplated by such agreements are consummated, potential acquisitions and strategic transactions.

ShowHide Related Items >><<
LNTH Lantheus
$61.32 /

+0.08 (+0.13%)

LNTH Lantheus
$61.32 /

+0.08 (+0.13%)

11/15/22 Truist
Point Biopharma price target lowered to $14 from $22 at Truist
11/14/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
10/12/22 Mizuho
Lantheus initiated with a Buy at Mizuho
10/06/22 JonesTrading
Lantheus initiated with a Buy at JonesTrading
LNTH Lantheus
$61.32 /

+0.08 (+0.13%)

LNTH Lantheus
$61.32 /

+0.08 (+0.13%)

Periodicals
Apple, Nvidia to be first-wave customers for TSMC Arizona factory, Nikkei says » 06:18
12/05/22
12/05
06:18
12/05/22
06:18
AAPL

Apple

$147.82 /

-0.58 (-0.39%)

, NVDA

Nvidia

$168.84 /

-2.615 (-1.53%)

, TSM

TSMC

$81.59 /

-1.13 (-1.37%)

Apple (AAPL) and Nvidia…

Apple (AAPL) and Nvidia (NVDA) are expected to be two of the first customers for Taiwan Semiconductor Manufacturing Company's (TSM) new Arizona factory, which is scheduled to start producing chips as early as year-end next year, Nikkei's Cheng Ting-Fang reports, citing sources briefed on the matter. Apple will be the most significant first-wave customer when the plant begins making chips, with Nvidia likely to follow. Reference Link

ShowHide Related Items >><<
TSM TSMC
$81.59 /

-1.13 (-1.37%)

NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

11/17/22 Needham
Nvidia price target raised to $200 from $155 at Needham
11/17/22 Jefferies
Nvidia fundamentals bottoming, should grow through 2023, says Jefferies
11/17/22 Stifel
Nvidia price target raised to $175 from $165 at Stifel
11/17/22 Wedbush
Nvidia price target raised to $175 from $160 at Wedbush
TSM TSMC
$81.59 /

-1.13 (-1.37%)

11/18/22 Erste Group
TSMC upgraded to Buy from Hold at Erste Group
11/15/22 Credit Suisse
Intel assumed with a Neutral at Credit Suisse
10/17/22 Northland
Teradyne price target lowered to $74 from $85 at Northland
10/13/22 Goldman Sachs
TSMC downgraded to Buy from Conviction Buy at Goldman Sachs
TSM TSMC
$81.59 /

-1.13 (-1.37%)

NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

TSM TSMC
$81.59 /

-1.13 (-1.37%)

NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

TSM TSMC
$81.59 /

-1.13 (-1.37%)

NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

TSM TSMC
$81.59 /

-1.13 (-1.37%)

NVDA Nvidia
$168.84 /

-2.615 (-1.53%)

AAPL Apple
$147.82 /

-0.58 (-0.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.